Related Experiment Videos

Vasculitis in children

Despina Eleftheriou1, Paul A Brogan

  • 1Department of Paediatric Rheumatology, Institute of Child Health and Great Ormond St Hospital for Children, London, UK. d.eleftheriou@ich.ucl.ac.uk

Best Practice & Research. Clinical Rheumatology
|June 11, 2009
PubMed

Insights

Pediatric systemic vasculitides are rare but serious. This review covers childhood vasculitides, focusing on causes, genetics, and improving treatments like biologics, while noting long-term cardiovascular risks.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Primary systemic vasculitides in children are rare but impactful, causing significant morbidity and mortality.
  • Understanding these conditions is crucial for timely diagnosis and management.
  • Recent advancements in classification and treatment offer new hope for affected children.

Purpose of the Study:

  • To provide a comprehensive overview of vasculitides predominantly affecting children.
  • To detail specific childhood vasculitides like Kawasaki Disease and Henoch Schönlein purpura.
  • To discuss emerging insights into genetic predispositions and infectious triggers.

Main Methods:

  • Review of current literature on pediatric systemic vasculitides.
  • Focus on diseases primarily affecting the pediatric population.
  • Inclusion of recent proposals for new classification criteria.

Main Results:

  • Infectious triggers are implicated in Kawasaki Disease and Henoch Schönlein purpura.
  • Genetic polymorphisms may influence disease susceptibility and complications.
  • Treatment strategies are evolving with immunosuppressants and biologic agents.

Conclusions:

  • New classification criteria for childhood vasculitis are under validation.
  • Long-term cardiovascular morbidity and endothelial health remain key concerns.
  • International collaboration is vital for advancing research and improving outcomes in pediatric vasculitis.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...